skip to Main Content
Jun 15 2021

ECASS III

Core Landmark Research, EBM, Landmark Research
Alteplase may be safely administered in treatment of acute ischemic stroke in the extended period of 3 to 4.5 hours after symptom onset
Read more
Back To Top
Login
Log in below to access learning modules.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.